Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Rey

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
The Journal of Infectious Diseases|June 2, 2011
Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trialOdile Launay, Corinne Desaint, Christine Durier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 6, 2019
Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Alafenamide Single-tablet Regimen for Human Immunodeficiency Virus Postexposure ProphylaxisPierre Gantner, Mojgan Hessamfar, Mohamed Faouzi Souala, et al.
The Journal of Infection|June 6, 2017
Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?Pierre Pradat, Pascal Pugliese, Isabelle Poizot-Martin, et al.
International Journal of Pharmaceutics|January 15, 2024
Biodistribution and pharmacokinetics of [<sup>89</sup>Zr]-anti-VEGF mAbs using PET in glioblastoma rat modelsLara García-Varela, Jessica Codesido, Alberto Perez-Pedrosa, et al.
AIDS (London, England)|February 14, 2018
Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIVPierre Pradat, Thomas Huleux, François Raffi, et al.
BMC Medicine|December 19, 2017
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to eliminationVictor Virlogeux, Fabien Zoulim, Pascal Pugliese, et al.
Expert Review of Anti-Infective Therapy|February 4, 2021
Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH)Tangui Barré, Teresa Rojas Rojas, Karine Lacombe, et al.
The Journal of Infectious Diseases|March 11, 2021
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2Ludivine Grzelak, Aurélie Velay, Yoann Madec, et al.
Plos One|September 22, 2018
Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patientsClotilde Allavena, Matthieu Hanf, David Rey, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2020
Spectrum and Incidence Trends of AIDS- and Non-AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS CohortIsabelle Poizot-Martin, Caroline Lions, Clotilde Allavena, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Infectious Diseases|June 2, 2011
Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trialOdile Launay, Corinne Desaint, Christine Durier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 6, 2019
Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Alafenamide Single-tablet Regimen for Human Immunodeficiency Virus Postexposure ProphylaxisPierre Gantner, Mojgan Hessamfar, Mohamed Faouzi Souala, et al.
The Journal of Infection|June 6, 2017
Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?Pierre Pradat, Pascal Pugliese, Isabelle Poizot-Martin, et al.
International Journal of Pharmaceutics|January 15, 2024
Biodistribution and pharmacokinetics of [<sup>89</sup>Zr]-anti-VEGF mAbs using PET in glioblastoma rat modelsLara García-Varela, Jessica Codesido, Alberto Perez-Pedrosa, et al.
AIDS (London, England)|February 14, 2018
Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIVPierre Pradat, Thomas Huleux, François Raffi, et al.
BMC Medicine|December 19, 2017
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to eliminationVictor Virlogeux, Fabien Zoulim, Pascal Pugliese, et al.
Expert Review of Anti-Infective Therapy|February 4, 2021
Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH)Tangui Barré, Teresa Rojas Rojas, Karine Lacombe, et al.
The Journal of Infectious Diseases|March 11, 2021
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2Ludivine Grzelak, Aurélie Velay, Yoann Madec, et al.
Plos One|September 22, 2018
Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patientsClotilde Allavena, Matthieu Hanf, David Rey, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2020
Spectrum and Incidence Trends of AIDS- and Non-AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS CohortIsabelle Poizot-Martin, Caroline Lions, Clotilde Allavena, et al.
Pageof 11